Related Experiment Video
Updated: Jul 9, 2025

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
Published on: January 10, 2025
Two Transgender Men Receiving Subdermal Testosterone Pellets for Gender Affirmation.
Sune L Wolf Pulsiano1, Jenna L Sarvaideo1
1Division of Endocrinology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Subdermal testosterone pellets offer a long-acting option for transgender men seeking gender affirmation. While well-tolerated in two cases, further research is needed to confirm efficacy and suitability.
Area of Science:
- Endocrinology
- Gender-affirming care
Background:
- Testosterone therapy is crucial for gender affirmation in transgender men.
- Subdermal testosterone pellets represent a less common delivery method.
- This report details two cases of transgender men using testosterone pellets.
Observation:
- Patient 1, a 47-year-old transgender man, switched from injections to pellets due to a desire for long-acting formulation. Pellets were well-tolerated but he returned to injections.
- Patient 2, a 20-year-old transgender man, opted for pellets to avoid injection pain and seek a long-acting option.
- Both patients experienced typical masculinizing effects from testosterone.
Findings:
- Subdermal testosterone pellets were generally well-tolerated in the reported cases.
- One patient preferred returning to injections despite pellet tolerance.
- The dosage used was comparable to that for hypogonadal cisgender men.
Implications:
- Subdermal testosterone pellets may be a viable option for testosterone delivery in transgender men.
- The limited number of cases precludes definitive conclusions.
- A prospective controlled study is recommended to evaluate testosterone pellets for transgender men.
More Related Videos
08:38Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
Published on: August 28, 2013
07:37Author Spotlight: Advancing Human Ovarian Repair and Cancer Studies with Surface Epithelium Organoids
Published on: August 16, 2024